Somatic Systems Stock Performance
| SMAS Stock | USD 0.0001 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Somatic Systems are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Somatic Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Somatic Systems is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Last Split Factor 1:20 | Last Split Date 2004-02-18 |
1 | VERA Launches as the Only AI Built for the Space Between Therapy Sessions - FinancialContent | 12/24/2025 |
Somatic Systems Relative Risk vs. Return Landscape
If you would invest 0.01 in Somatic Systems on October 3, 2025 and sell it today you would earn a total of 0.00 from holding Somatic Systems or generate 0.0% return on investment over 90 days. Somatic Systems is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Somatic, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Somatic Systems Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Somatic Systems' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Somatic Systems, and traders can use it to determine the average amount a Somatic Systems' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SMAS |
Based on monthly moving average Somatic Systems is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Somatic Systems by adding Somatic Systems to a well-diversified portfolio.
Somatic Systems Fundamentals Growth
Somatic Stock prices reflect investors' perceptions of the future prospects and financial health of Somatic Systems, and Somatic Systems fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Somatic Stock performance.
| Profit Margin | (2.23) % | ||||
| Operating Margin | (4.97) % | ||||
| Current Valuation | 1.46 M | ||||
| Shares Outstanding | 14.6 B | ||||
| Price To Sales | 13.59 X | ||||
| Revenue | 107.42 K | ||||
| Gross Profit | 97.66 K | ||||
| EBITDA | (215.35 K) | ||||
| Net Income | (239.08 K) | ||||
| Cash And Equivalents | 7.67 K | ||||
| Total Debt | 353.61 K | ||||
| Cash Flow From Operations | (199.9 K) | ||||
| Total Asset | 189.28 K | ||||
| Retained Earnings | (1.16 M) | ||||
About Somatic Systems Performance
Assessing Somatic Systems' fundamental ratios provides investors with valuable insights into Somatic Systems' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Somatic Systems is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Somatic Systems, Inc. provides drug-free and non-surgical approach to movement disorders, musculoskeletal problems, and pain relief. The company was founded in 1987 and is based in Northampton, Massachusetts with additional offices in Virginia Beach, Virginia and New York, New York. Somatic Systems is traded on OTC Exchange in the United States.Things to note about Somatic Systems performance evaluation
Checking the ongoing alerts about Somatic Systems for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Somatic Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Somatic Systems generated a negative expected return over the last 90 days | |
| Somatic Systems has some characteristics of a very speculative penny stock | |
| Somatic Systems currently holds 353.61 K in liabilities. Somatic Systems has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Somatic Systems' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 107.42 K. Net Loss for the year was (239.08 K) with profit before overhead, payroll, taxes, and interest of 97.66 K. | |
| Somatic Systems currently holds about 7.67 K in cash with (199.9 K) of positive cash flow from operations. | |
| Latest headline from news.google.com: VERA Launches as the Only AI Built for the Space Between Therapy Sessions - FinancialContent |
- Analyzing Somatic Systems' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Somatic Systems' stock is overvalued or undervalued compared to its peers.
- Examining Somatic Systems' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Somatic Systems' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Somatic Systems' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Somatic Systems' stock. These opinions can provide insight into Somatic Systems' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Somatic Stock Analysis
When running Somatic Systems' price analysis, check to measure Somatic Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Somatic Systems is operating at the current time. Most of Somatic Systems' value examination focuses on studying past and present price action to predict the probability of Somatic Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Somatic Systems' price. Additionally, you may evaluate how the addition of Somatic Systems to your portfolios can decrease your overall portfolio volatility.